Elicio Therapeutics, Inc.

NASDAQ:ELTX

Biotechnology

Healthcare
$2.70 -18.90%

-$0.89 today

Market cap
$51.48M
Beta
1.14
P/E (TTM)
-1.7
EPS (TTM)
-$2.21
52W Low $2.66High $16.00

Volume 0.41M

Average 0.34M

Price history

Elicio Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-66.67%

Period high

$14.85

Period low

$2.70

Latest

$2.70

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KAug 13, 2026Aug 13, 2026
10-QAug 13, 2026Aug 13, 2026
4Jul 17, 2026Jul 17, 2026
4Jul 17, 2026Jul 17, 2026
4Jul 17, 2026Jul 17, 2026
4Jul 17, 2026Jul 17, 2026
SC 13GJul 16, 2026Jul 16, 2026
SC 13G/AJul 8, 2026Jul 8, 2026
424B5Jul 2, 2026Jul 2, 2026
8-KJul 2, 2026Jul 2, 2026
8-KJun 24, 2026Jun 24, 2026
8-KJun 17, 2026Jun 17, 2026
8-KJun 15, 2026Jun 15, 2026
10-QMay 11, 2026May 11, 2026
8-KMay 11, 2026May 11, 2026

Competitors

Who does Elicio Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ELTX's filings, answered from its disclosures.

What is the latest ELTX filing?

The latest filing shown is 10-Q dated Aug 13, 2026.

How many recent filings does ELTX have?

Intrinsic Alpha currently shows 20 recent filings for ELTX.